US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 41.080
  • -0.010-0.02%
Close Nov 7 16:00 ET
  • 41.680
  • +0.600+1.46%
Post 17:17 ET
1.96BMarket Cap-17783P/E (TTM)

Mirum Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mirum Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
81.99M
+71.80%
EPS
-0.46
+19.58%
Analyst Rating
Buy

Nov 7, 2024

Mirum Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 87.571M--
Nov 12, 20242024/Q3-- / 81.993M--
Aug 7, 20242024/Q277.875M / 75.081M--
May 8, 20242024/Q169.222M / 70.171M--
Feb 28, 20242023/Q469.554M / 67.861M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 87.571M--
Nov 12, 20242024/Q3-- / 81.993M--
Aug 7, 20242024/Q277.875M / 75.081M--
May 8, 20242024/Q169.222M / 70.171M--
Feb 28, 20242023/Q469.554M / 67.861M--

Unlock Free Earnings Estimates

Mirum Pharmaceuticals Earnings Reports

  • Mirum Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:17 ET

  • Mirum Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 16:23 ET

  • Mirum Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 15 17:11 ET

  • Mirum Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data